ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
간암 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 14.3%로 성장할 전망이며, 57억 5,000만 달러로 성장이 예측됩니다. 예측 기간 동안의 성장은 노인 인구의 확대, 헬스케어 지출의 증가, 저침습 치료에 대한 수요 증가, 전문 클리닉 증가, 의료 투어리즘 성장에 기인하고 있습니다. 이 기간 주요 동향으로는 진단 기술의 발전, 표적 요법의 개발, 병용 요법의 도입, 외과 수술의 기술 혁신, 방사선 치료 기술의 진보 등을 들 수 있습니다.
알코올 소비량 증가가 간암 시장의 확대를 견인할 것으로 예측됩니다. 알코올 소비량은 그 양과 빈도에 의해 측정되는 것이 일반적이지만, 미디어에서 선전되어 다양한 상황에서 입수하기 쉬워짐으로써 사람들이 일상의 스트레스를 해소하고 사회적 교류를 촉진하며 릴렉스 효과를 높이는 데 도움이 되고 있기 때문에 증가 일로를 걷고 있습니다. 그러나 알코올의 과다섭취는 간경변이나 염증, DNA의 손상을 유발하고 세포의 이상증식을 촉진함으로써 간암의 위험을 높입니다. 예를 들어, 2023년 3월 아일랜드에 기반을 둔 데이터 수집 기관 National Drugs Library는 15세 이상 개인의 평균 알코올 소비량이 2022년에는 1인당 순 알코올 10.2리터로 증가했고, 2021년부터 7.6% 증가했다고 보고했습니다. 이 알코올 소비량의 증가가 간암 시장의 성장에 기여하고 있습니다.
간암 시장의 주요 기업은 치료 정밀도 향상, 환자 결과 개선, 부작용 완화를 목표로 하여, 선진 치료 기기, 특히 경 카테터적 동맥 화학 색전 요법(TACE)의 개발에 주력하고 있습니다. TACE는 치료 효과를 높이기 위해 혈액 공급을 차단하면서 화학요법을 간 종양에 직접 투여하는 저침습 수술입니다. 예를 들어, 일본의 의료 기술 기업인 테르모 주식회사는 2023년 11월 간암 관리를 지원하는 2개의 혁신적인 치료 기기인 Oclusafe와 LifePearl을 출시했습니다. 이 기기들은 인도에서 가장 흔한 원발성 간암인 간세포암(HCC)의 치료를 개선하기 위해 설계됐으며 매년 2만 명 이상의 신규 환자가 발생하고 있습니다. Occlusafe는 Balloon-TACE(B-TACE)로 알려진 최첨단 치료법의 일부로, 손기술 중 풍선을 사용하여 혈류를 차단함으로써 TACE의 정확도 및 효과를 높입니다. 라이프 펄은 폴리에틸렌글리콜(PEG) 색전 미소구로 이루어져 있으며 화학요법제를 충전할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 간암 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 간암 시장 : 성장률 분석
세계의 간암 시장 실적 : 규모 및 성장(2019-2024년)
세계의 간암 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 간암 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 간암 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
간아종
간내 담관암
간세포암
섬유층 암
세계의 간암 시장 : 간암 스테이지별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
조기
중급 스테이지
상급 단계
세계의 간암 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
표적요법
방사선치료
수술
화학요법
면역요법
세계의 간암 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
외래수술센터(ASC)
암 연구기관
세계의 간암 시장 : 간아종 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
상피성 간아종
상피성 및 간엽성 혼합 간아종
세계의 간암 시장 : 간내 담관암 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
종괴 형성성 담관암
담관 주위 침윤성 담관암
담관내 증식성 담관암
세계의 간암 시장 : 간세포암 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
섬유층상 간세포암
종래의 간세포암
스킬스 간세포암
명세포 간세포암
림프 상피종 유사 간세포 암
세계의 간암 시장 : 섬유층 암 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
고전적 섬유층 암
혼합 섬유층상 간세포암 및 통상형 간세포암
제7장 지역별 및 국가별 분석
세계의 간암 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 간암 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
간암 시장 : 경쟁 구도
간암 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sanofi SA
Bristol-Myers Squibb Company
Thermo Fisher Scientific Inc.
AstraZeneca PLC
Abbott Laboratories
Novartis AG
Eli Lilly and Company
Siemens Healthineers AG
Terumo Corporation
Eisai Co. Ltd.
Qiagen NV
Exelixis Inc.
BeiGene Ltd.
RayzeBio Inc.
Innovent Biologics Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
간암 시장(2029년) : 새로운 기회를 제공하는 국가
간암 시장(2029년) : 새로운 기회를 제공하는 부문
간암 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Liver cancer is a type of malignant disease that begins in the liver cells, primarily hepatocytes, and has the potential to spread to other organs. It is linked to risk factors such as chronic infections with hepatitis B and C, cirrhosis, excessive alcohol use, and non-alcoholic fatty liver disease (NAFLD). The disease is often diagnosed in its advanced stages, making early detection and treatment essential for improving survival rates.
The main forms of liver cancer include hepatoblastoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and fibrolamellar carcinoma. Hepatoblastoma is a rare form of liver cancer that typically affects young children and arises from immature liver cells. Liver cancer progresses through various stages, including the early, intermediate, and advanced stages. Treatment options include targeted therapy, radiation therapy, surgery, chemotherapy, and immunotherapy. The primary end users of these treatments are hospitals, specialty clinics, ambulatory surgical centers, and cancer research institutes.
The liver cancer market research report is one of a series of new reports from The Business Research Company that provides liver cancer market statistics, including the liver cancer industry global market size, regional shares, competitors with the liver cancer market share, detailed liver cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the liver cancer industry. This liver cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The liver cancer market size has grown rapidly in recent years. It will grow from $2.94 billion in 2024 to $3.37 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth during the historic period can be attributed to the increasing global incidence of liver cancer, the rising prevalence of hepatitis B and C infections, higher rates of non-alcoholic fatty liver disease, government initiatives encouraging early diagnosis, and growing awareness about liver health.
The liver cancer market size is expected to see rapid growth in the next few years. It will grow to $5.75 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth during the forecast period can be attributed to the expanding geriatric population, higher healthcare spending, increasing demand for minimally invasive treatments, a rise in specialty clinics, and the growth of medical tourism. Key trends during this period include advancements in diagnostic technologies, the development of targeted therapies, the introduction of combination therapies, technological innovations in surgical procedures, and progress in radiotherapy techniques.
The growing consumption of alcohol is expected to drive the expansion of the liver cancer market. Alcohol consumption, typically measured by its quantity and frequency, has been rising as it helps people relieve daily stress, fosters social interaction, and enhances relaxation, with its promotion in media and increased accessibility in various settings. However, excessive alcohol intake can lead to liver cirrhosis, inflammation, and DNA damage, which increases the risk of liver cancer by encouraging abnormal cell growth. For example, in March 2023, the National Drugs Library, an Ireland-based data collection organization, reported that the average alcohol consumption for individuals aged 15 and older increased to 10.2 liters of pure alcohol per capita in 2022, reflecting a 7.6% rise from 2021. This increase in alcohol consumption is contributing to the growth of the liver cancer market.
Leading companies in the liver cancer market are focusing on developing advanced therapy devices, specifically transcatheter arterial chemoembolization (TACE), to improve treatment precision, patient outcomes, and reduce side effects. TACE is a minimally invasive procedure that delivers chemotherapy directly to a liver tumor while blocking its blood supply to increase the treatment's effectiveness. For example, in November 2023, Terumo Corporation, a Japan-based medical technology company, launched two innovative therapy devices, Occlusafe and LifePearl, to assist in the management of liver cancer. These devices are designed to improve the treatment of hepatocellular carcinoma (HCC), the most common type of primary liver cancer in India, which sees over 20,000 new cases each year. Occlusafe is part of a cutting-edge therapy known as Balloon-TACE (B-TACE), which increases the precision and effectiveness of TACE by using a balloon to block blood flow during the procedure. LifePearl consists of polyethylene glycol (PEG) embolization microspheres, which can be loaded with chemotherapeutic agents.
In August 2023, TriSalus Life Sciences, a U.S.-based medical technology company focused on oncology, merged with MedTech Acquisition Corporation. This merger is intended to strengthen TriSalus Life Sciences' financial position and support the development of innovative treatments for liver and pancreatic tumors. MedTech Acquisition Corporation is a special purpose acquisition company (SPAC) that targets mergers with existing medical technology firms.
Major players in the liver cancer market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Siemens Healthineers AG, Terumo Corporation, Eisai Co. Ltd., Qiagen N.V., Exelixis Inc., BeiGene Ltd., RayzeBio Inc., Innovent Biologics Inc., Celsion Corporation.
North America was the largest region in the liver cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in liver cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the liver cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The liver cancer market consists of revenues earned by entities providing services such as early screening, palliative care, liver transplantation, personalized medicine, and radiofrequency ablation. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver cancer market also includes sales of diagnostic imaging equipment, biomarker tests, embolization devices, and supportive care medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Liver Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on liver cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for liver cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver cancer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Liver Cancer Market Characteristics
3. Liver Cancer Market Trends And Strategies
4. Liver Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Liver Cancer Growth Analysis And Strategic Analysis Framework
5.1. Global Liver Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Liver Cancer Market Growth Rate Analysis
5.4. Global Liver Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Liver Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Liver Cancer Total Addressable Market (TAM)
6. Liver Cancer Market Segmentation
6.1. Global Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hepatoblastoma
Intrahepatic Cholangiocarcinoma
Hepatocellular Carcinoma
Fibrolamellar Carcinoma
6.2. Global Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early Stage
Intermediate Stage
Advanced Stage
6.3. Global Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Therapy
Radiation Therapy
Surgery
Chemotherapy
Immunotherapy
6.4. Global Liver Cancer Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
6.5. Global Liver Cancer Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Epithelial Hepatoblastoma
Mixed Epithelial and Mesenchymal Hepatoblastoma
6.6. Global Liver Cancer Market, Sub-Segmentation Of Intrahepatic Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass-forming Cholangiocarcinoma
Periductal Infiltrating Cholangiocarcinoma
Intraductal Growing Cholangiocarcinoma
6.7. Global Liver Cancer Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fibrolamellar Hepatocellular Carcinoma
Conventional Hepatocellular Carcinoma
Scirrhous Hepatocellular Carcinoma
Clear Cell Hepatocellular Carcinoma
Lymphoepithelioma-like Hepatocellular Carcinoma
6.8. Global Liver Cancer Market, Sub-Segmentation Of Fibrolamellar Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Classic Fibrolamellar Carcinoma
Mixed Fibrolamellar and Conventional Hepatocellular Carcinoma
7. Liver Cancer Market Regional And Country Analysis
7.1. Global Liver Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Liver Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Liver Cancer Market
8.1. Asia-Pacific Liver Cancer Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Liver Cancer Market
9.1. China Liver Cancer Market Overview
9.2. China Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Liver Cancer Market
10.1. India Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Liver Cancer Market
11.1. Japan Liver Cancer Market Overview
11.2. Japan Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Liver Cancer Market
12.1. Australia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Liver Cancer Market
13.1. Indonesia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Liver Cancer Market
14.1. South Korea Liver Cancer Market Overview
14.2. South Korea Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Liver Cancer Market
15.1. Western Europe Liver Cancer Market Overview
15.2. Western Europe Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Liver Cancer Market
16.1. UK Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Liver Cancer Market
17.1. Germany Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Liver Cancer Market
18.1. France Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Liver Cancer Market
19.1. Italy Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Liver Cancer Market
20.1. Spain Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Liver Cancer Market
21.1. Eastern Europe Liver Cancer Market Overview
21.2. Eastern Europe Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Liver Cancer Market
22.1. Russia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Liver Cancer Market
23.1. North America Liver Cancer Market Overview
23.2. North America Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Liver Cancer Market
24.1. USA Liver Cancer Market Overview
24.2. USA Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Liver Cancer Market
25.1. Canada Liver Cancer Market Overview
25.2. Canada Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Liver Cancer Market
26.1. South America Liver Cancer Market Overview
26.2. South America Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Liver Cancer Market
27.1. Brazil Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Liver Cancer Market
28.1. Middle East Liver Cancer Market Overview
28.2. Middle East Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Liver Cancer Market
29.1. Africa Liver Cancer Market Overview
29.2. Africa Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Liver Cancer Market Competitive Landscape And Company Profiles
30.1. Liver Cancer Market Competitive Landscape
30.2. Liver Cancer Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Liver Cancer Market Other Major And Innovative Companies
31.1. Sanofi S.A.
31.2. Bristol-Myers Squibb Company
31.3. Thermo Fisher Scientific Inc.
31.4. AstraZeneca PLC
31.5. Abbott Laboratories
31.6. Novartis AG
31.7. Eli Lilly and Company
31.8. Siemens Healthineers AG
31.9. Terumo Corporation
31.10. Eisai Co. Ltd.
31.11. Qiagen N.V.
31.12. Exelixis Inc.
31.13. BeiGene Ltd.
31.14. RayzeBio Inc.
31.15. Innovent Biologics Inc.
32. Global Liver Cancer Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Liver Cancer Market
34. Recent Developments In The Liver Cancer Market
35. Liver Cancer Market High Potential Countries, Segments and Strategies
35.1 Liver Cancer Market In 2029 - Countries Offering Most New Opportunities
35.2 Liver Cancer Market In 2029 - Segments Offering Most New Opportunities
35.3 Liver Cancer Market In 2029 - Growth Strategies
